Source: PharmaLive

Replay: Replay, MD Anderson partner to create first engineered cell therapy for solid tumors

Genome engineering company Replay and The University of Texas' MD Anderson Cancer Center have joined forces to launch Syena, an oncology product company.

Read full article »
Replay's Competitors | Replay's News | Replay's Financials
Stay up-to-date with the latest news on Replay
Est. Annual Revenue
$100K-5.0M
Est. Employees
25-100
Lachlan MacKinnon's photo - Co-Founder & CEO of Replay

Co-Founder & CEO

Lachlan MacKinnon

CEO Approval Rating

90/100

Read more
Stay up-to-date with the latest news on Replay